Richard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery ConsortiumGlobeNewsWire • 02/19/20
Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/07/19
Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 11/08/19
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/30/19
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial ResultsGlobeNewsWire • 10/29/19
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/04/19
Corvus Pharmaceuticals: Insider Buying Ahead Of Potential Turnaround In Second Half Of 2019Seeking Alpha • 07/04/19
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/13/19